In the context of liver fibrosis, Smad7 acts as a negative feedback regulator, inhibiting the TGF-β1/Smad signaling by preventing the binding of activated TβRI to Smad2/Smad3 [15]. The gene discussed is SMAD3; the disease is Hepatic fibrosis.